Related Experiment Videos
A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific
Insights
This study tracked 40 children with Epstein-Barr-Virus (EBV) infection, finding that cell-mediated immunity, measured by leukocyte migration inhibition, developed later in the disease course, correlating with anti-EBNA antibody appearance.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Epstein-Barr-Virus (EBV) infection is common in children.
- Understanding the immune response to EBV is crucial for diagnosis and management.
- Cell-mediated immunity plays a role in EBV infection clearance.
Purpose of the Study:
- To investigate the clinical course and serological changes in children with EBV infection.
- To examine the development of specific cell-mediated immune responses to EBV.
- To establish relationships between serological markers and immune responses.
Main Methods:
- Longitudinal follow-up of 40 children with EBV infection for 6-24 months.
- Monitoring clinical symptoms and serological markers including heterophil antibodies, anti-VCA IgM/IgG, anti-EBNA, and early antigen antibodies (D and R components).
- Assessing cell-mediated immunity using leukocyte migration inhibition tests.
Main Results:
- Typical clinical course observed in most children, but heterophil antibodies were only detected in 60% of cases.
- Anti-VCA IgM and IgG antibodies were present in all patients during the acute phase; anti-EBNA was absent.
- Antibodies against the D component of early antigen were absent in children under three, while anti-R antibodies appeared 5-6 months post-infection in 73% of cases.
- Specific leukocyte migration inhibition was observed during convalescence or later, with a correlation established between anti-EBNA appearance and this cell-mediated response.
Conclusions:
- Serological profiles in children with EBV infection vary, particularly in younger age groups.
- Cell-mediated immune response, indicated by leukocyte migration inhibition, develops later in the EBV infection course.
- The appearance of anti-EBNA antibodies is linked to the development of specific cell-mediated immunity in EBV-infected children.
Abstract:
The clinical course, serological changes and the development of the specific cell-mediated immune response to Epstein-Barr-Virus (EBV), measured in terms of leukocyte migration inhibition, were followed in 40 children suffering from an EBV infection. The patients were followed for between six and 24 months. Although the majority of the children were under six years of age, they presented a typical clinical course; heterophil antibodies could only be demonstrated in 60% of the cases. Anti-VAC-IgM and IgG antibodies were found in all patients during the acute phase, but no anti-EBNA could be demonstrated. In children under three years of age, no antibodies against the D component of the early antigen were found; this antibody was found in 50% of the adolescents. An antibody against the R component of the early antigen could be demonstrated in 73% of the children five to six months after the onset of the disease. Specific leukocyte migration inhibition was present only during convalescence or later. A relationship between the appearance of anti-EBNA and the development of specific leukocyte migration inhibition has been established.